Skip to content
A9188Assembly2023-2024 SessionSame asS1720

Ban Tianeptine Sodium Sales

Official title

“Adds tianeptine sodium to the list of Schedule II of controlled substances”

Sponsor Edward BraunsteinAD-26Affects Health
Status
In Assembly Committee
Health
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill adds tianeptine sodium to New York's Schedule II controlled substances list.

Why it matters

  1. Criminalizes possession and distribution. By scheduling tianeptine sodium as a Schedule II substance, unauthorized possession, sale, or distribution will become a criminal offense, potentially leading to arrests, prosecutions, and significant legal consequences for individuals and businesses.

  2. Limits medical and research access. Schedule II substances are tightly regulated, so this change would restrict tianeptine sodium’s availability for medical or scientific research purposes, requiring special licenses and oversight, which could slow or complicate legitimate studies.

  3. Responds to public health concerns. The amendment appears to address increasing reports of misuse, addiction, and adverse health effects linked to tianeptine, a substance sometimes marketed as a supplement but linked to opioid-like effects and overdoses.

  4. Aligns New York with other states and federal scrutiny. Several states and the FDA have taken action against tianeptine due to safety concerns. This move signals New York’s intent to curtail its unregulated sale and align with broader efforts to control emerging drugs of abuse.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Ban Tianeptine Sodium Sales

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Edward Braunstein

Assembly Member · Assembly District 26

Chair, Corporations, Authorities and Commissions

No co-sponsors yet.

History

  1. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S1720Senate

Ban Tianeptine Sodium

In Senate Committee · Health · Sponsor James Skoufis

Impact 6 · Moderate0% to pass

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

9188

IN ASSEMBLY

February 12, 2024

Introduced by M. of A. BRAUNSTEIN -- read once and referred to the Committee on Health

AN ACT to amend the public health law, in relation to adding tianeptine sodium to schedule II of controlled substances

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision (e) of schedule II of section 3306 of the public health law is amended by adding a new paragraph 5 to read as follows:

(5) Tianeptine sodium.

§ 2. This act shall take effect on the ninetieth day after it shall have become a law.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD04681-01-3

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.